Undiagnosed Acquired Hemophilia A: Presenting as Recurrent Gastrointestinal Bleeding

Acute gastrointestinal bleeding (GIB) is a frequently encountered medical emergency and it can be life-threatening depending on the etiology and the clinical condition of the patient. The most common causes of GIB are peptic ulcer disease, aspirin-induced gastritis, variceal hemorrhage, esophagitis, neoplasms like gastric cancer. Acquired hemophilia causing acute gastrointestinal bleed is extremely rare and only a few cases are reported worldwide. Acquired hemophilia A (AHA) is a rare disorder caused by the production of autoantibodies that inactivates clotting factor VIII. We present a case of upper gastrointestinal bleed due to AHA which was undiagnosed for two years. A 74-year-old patient with a history of myasthenia gravis, presented with anemia, and GIB. She underwent multiple endoscopies without a clear bleeding source. Coagulation studies showed isolated activated partial thromboplastin time prolongation which was not corrected by mixing study. Factor VIII activity was low and Bethesda titer showed elevated inhibitor levels. Factor Eight Bypassing Agent, recombinant factor VIIa, and steroids were given to control bleeding. Her clinical condition worsened, and she passed away. Elderly patients presenting with an undiagnosed source of GIBs, inconclusive endoscopic studies should be evaluated for acquired coagulopathies, especially in those with a history of autoimmune diseases and malignancies. Prompt diagnosis and treatment are warranted as it carries a high mortality. Part of the case presentation was presented as an abstract at a regional conference

[1]  Manojna Konda,et al.  Acquired hemophilia A , 2019, Proceedings.

[2]  Jae Hwang Cha,et al.  Acquired Hemophilia A with Gastrointestinal Bleeding , 2019, Clinical endoscopy.

[3]  T. Kondo,et al.  Acquired hemophilia A in solid cancer: Two case reports and review of the literature , 2018, World journal of clinical cases.

[4]  G. Rivard,et al.  Management of acquired hemophilia A: Review of current evidence. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[5]  N. Botross,et al.  Acquired Hemophilia of Unknown Etiology in an Elderly Man: Case Report , 2018, The American journal of case reports.

[6]  A. Lobo,et al.  Acute upper gastrointestinal bleeding. , 2015, Clinical medicine.

[7]  C. Leissinger,et al.  Acquired hemophilia A: emerging treatment options , 2015, Journal of blood medicine.

[8]  W. Tsay,et al.  A study of 65 patients with acquired hemophilia A in Taiwan. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[9]  J. Samra,et al.  Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. , 2014, World journal of gastrointestinal pathophysiology.

[10]  Y. Sakurai,et al.  Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder , 2014, Journal of immunology research.

[11]  H. Schwarz,et al.  Factor Eight Inhibitor Bypassing Activity , 2012 .

[12]  C. Kessler,et al.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A , 2009, Haematologica.

[13]  S. Kaveri,et al.  Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia1 , 2008, The Journal of Immunology.

[14]  G. Mariani,et al.  Acquired hemophilia A: A concise review , 2005, American journal of hematology.

[15]  S. Sallah Treatment of acquired haemophilia with factor eight inhibitor bypassing activity , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  G. Longstreth Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. , 1995, The American journal of gastroenterology.